Denali Therapeutics
DNLI
$23.64
Share price
4.08%
Change (1 day)
-25.08%
Change (1 year)
Categories
Denali Therapeutics (DNLI) - Cash on Hand
Cash on Hand as of December 2024 : A$1.33 Billion
According to Denali Therapeutics
's latest financial reports the company has A$1.33 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Denali Therapeutics - Cash on Hand chart (from 2016 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$1.33 B | -11.87% |
| 2023-12-31 | A$1.51 B | -22.67% |
| 2022-12-31 | A$1.96 B | 64.49% |
| 2021-12-31 | A$1.19 B | -37.55% |
| 2020-12-31 | A$1.91 B | 222.19% |
| 2019-12-31 | A$0.59 B | -9.99% |
| 2018-12-31 | A$0.65 B | 26.66% |
| 2017-12-31 | A$0.52 B | 110.32% |
| 2016-12-31 | A$0.24 B | 486.3% |
| 2015-12-31 | A$42.19 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | A$1.53 B | 15.32% | Jersey |
 | A$1.47 B | 10.91% | 🇺🇸 USA |
 | A$1.85 M | -99.86% | 🇺🇸 USA |
 | A$0.20 B | -84.93% | 🇬🇧 UK |